Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution

Endocrine ◽  
2021 ◽  
Author(s):  
Tommaso Porcelli ◽  
Cristina Luongo ◽  
Francesca Sessa ◽  
Michele Klain ◽  
Stefania Masone ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Cancer Patients ◽  
Life Experience ◽  
Real Life ◽  
Single Institution ◽  
Term Management

scholarly journals Lenvatinib Long-Term Responses in Refractory Thyroid Cancer: Our Mono-Institutional Real-Life Experience with the Multidisciplinary Approach and Review of Literature

Oncology ◽  
2019 ◽  
Vol 97 (4) ◽  
pp. 206-210 ◽  
Author(s):  
Nerina Denaro ◽  
Adele Latina ◽  
Flora Cesario ◽  
Fabio Bramardi ◽  
Lauro Corrado ◽  
...  
Keyword(s):  
Thyroid Cancer ◽  
Multidisciplinary Approach ◽  
Life Experience ◽  
Real Life ◽  
Review Of Literature

scholarly journals DOUBLE‐HIT (DHL) AND TRIPLE‐HIT LYMPHOMAS (THL): REAL LIFE EXPERIENCE OF 46 CONSECUTIVE PATIENTS FROM A SINGLE INSTITUTION IN SPAIN

2021 ◽  
Vol 39 (S2) ◽  
Author(s):  
E. M. Gonzalez Barca ◽  
J. M. Sancho ◽  
J. Rovira ◽  
N. Kelleher ◽  
M. Kara ◽  
...  
Keyword(s):  
Life Experience ◽  
Real Life ◽  
Single Institution ◽  
Double Hit

scholarly journals Patient-Reported Outcomes, Health-Related Quality of Life, and Clinical Outcomes for Urothelial Cancer Patients Receiving Chemo- or Immunotherapy: A Real-Life Experience

2021 ◽  
Vol 10 (9) ◽  
pp. 1852
Author(s):  
Gry Assam Taarnhøj ◽  
Henriette Lindberg ◽  
Christoffer Johansen ◽  
Helle Pappot
Keyword(s):  
Quality Of Life ◽  
Cancer Patients ◽  
Patient Reported Outcomes ◽  
Life Experience ◽  
Locally Advanced ◽  
Neoadjuvant Treatment ◽  
Real Life ◽  
Oncological Treatment ◽  
Patient Reported

Patients with urothelial cell carcinoma (UCC) often have comorbidities, which cause trouble for the completion of oncological treatment, and little is known about their quality of life (QoL). The aim of the present study was to obtain and describe patient-reported outcomes (PRO) and QoL data from UCC patients in the treatment for locally advanced muscle-invasive or metastatic UCC. A total of 79 patients with UCC completed four questionnaires (EORTC QLQ-C30, QLQ-BLM30, HADS, and select PRO-CTCAE™ questions) once weekly during their treatment. From those, 26 patients (33%) underwent neoadjuvant treatment for local disease while 53 patients (67%) were treated for metastatic disease. Of all patients, 54% did not complete the planned treatment due to progression, nephrotoxicity, death, or intolerable symptoms during treatment. The five most prevalent PRO-CTCAE grade ≥ 2 symptoms were frequent urination (37%), fatigue (35%), pain (31%), dry mouth (23%), and swelling of the arms or legs (23%). The baseline mean overall QoL was 61 (±SD 24) for all patients (neoadjuvant (73, ±SD 19) and metastatic (54, ±SD 24)) and remained stable over the course of treatment for both groups. A stable overall QoL was observed for the patients in this study. More than half of the patients did not, however, complete the planned treatment. Further supportive care is warranted for bladder cancer patients.

Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience

2007 ◽  
Vol 67 (5) ◽  
pp. 717-719 ◽  
Author(s):  
L C Coates ◽  
L S Cawkwell ◽  
N W F Ng ◽  
A N Bennett ◽  
D J Bryer ◽  
...  
Keyword(s):  
Psoriatic Arthritis ◽  
Life Experience ◽  
Real Life ◽  
Sustained Response

Biologics registries

2013 ◽  
pp. 257-263
Author(s):  
David Isenberg ◽  
Angela Zink
Keyword(s):  
Rheumatoid Arthritis ◽  
Life Experience ◽  
Real Life ◽  
Cancer Development ◽  
Controlled Trials ◽  
Side Effect Profile ◽  
Risk Of Infection ◽  
Biologic Drugs ◽  
Double Blind

Double-blind controlled trials undertaken over the past two decades have established the short-term effectiveness and side-effect profile of biologic drugs for patients with rheumatoid arthritis and related diseases. However, the development of biologics registers to capture ’real-life experience’ and explore long-term effectiveness and complications is equally important. In this chapter, we demonstrate how these registers have identified long-term joint benefits, a reduction in cardiovascular mortality, reassurance concerning fears about cancer development, and a balanced view of the risk of infection.

Everolimus and long-term decline in renal function after liver transplantation: real-life experience with measured GFR

2020 ◽  
Vol 55 (6) ◽  
pp. 718-724
Author(s):  
Fredrik Åberg ◽  
John Berntsson ◽  
Gustaf Herlenius ◽  
Maria Castedal ◽  
William Bennet
Keyword(s):  
Liver Transplantation ◽  
Renal Function ◽  
Life Experience ◽  
Real Life ◽  
Measured Gfr

scholarly journals P559 Real-life experience with long-term maintenance of golimumab in ulcerative colitis patients

2019 ◽  
Vol 13 (Supplement_1) ◽  
pp. S393-S394
Author(s):  
M Iborra ◽  
N García-Morales ◽  
S Rubio ◽  
O Nantes Castillejo ◽  
F Bertoletti ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Life Experience ◽  
Real Life ◽  
Term Maintenance
Sign in / Sign up

Export Citation Format

Share Document